• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Compliance Perspectives: How to Comply with the CMS 60-Day Overpayment Repayment Rule

Compliance Perspectives: How to Comply with the CMS 60-Day Overpayment Repayment Rule

by Glenn S. Demby | Sep 1, 2023 | Compliance Perspectives-lca, Essential, Lab Compliance Advisor

While overpayments may not be your fault, they expose your lab to the risk of liability under the Affordable Care Act.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
September 2023 Labs in Court

September 2023 Labs in Court

by Glenn S. Demby | Aug 31, 2023 | Essential, Lab Compliance Advisor, Labs in Court

In last month’s key cases, Illumina and Guardant seek to dismiss lawsuit related to trade secrets and breach of contract.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
OIG Sheds Light on Kickback Implications of Online Healthcare Directories

OIG Sheds Light on Kickback Implications of Online Healthcare Directories

by Glenn S. Demby | Aug 29, 2023 | Essential, National Lab Reporter, OIG-nir

Recent advisory opinion offers insight on how healthcare providers may want to structure arrangements involving online directories.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
August 2023 Labs in Court

August 2023 Labs in Court

by Glenn S. Demby | Jul 31, 2023 | Essential, Lab Compliance Advisor, Labs in Court

Last month’s key cases involved the outcome of a UHC lawsuit and fines for misleading claims about a COVID-19 test.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It

Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It

by Glenn S. Demby | Jul 31, 2023 | Enforcement-nir, Essential, National Lab Reporter

False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com